Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats

Kangiser, Megan M; Dwoskin, Linda P; Zheng, Guangrong; Crooks, Peter A; Stairs, Dustin J

doi:10.1097/fbp.0000000000000340

Public

Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.

Published in Behavioural pharmacology • Feb 1, 2018

NobleIDNI5P34W63R39S71

Authors:

Megan M Kangiser

,

Linda P Dwoskin

,

Guangrong Zheng

Abstract

Methamphetamine is a potent psychostimulant with high abuse rates. Currently, there is no Food and Drug Administration-approved pharmacotherapy for methamphetamine addiction. Ideally, a pharmacotherapy should selectively decrease methamphetamine self-administration without affecting responding for o...

Discussions